Kuehn Law investigates Viking Therapeutics officers and directors
AI Summary- Kuehn Law investigates potential fiduciary-duty breaches by Viking Therapeutics officers and directors.
- Shareholders are identified as potentially entitled to damages and corporate governance reforms.
- September 28, 2026 release lists Justin Kuehn as the shareholder contact.